InnovHeart
  • Welcome
  • Clinical Needs
  • Who We Are
  • Careers
  • Contact
Seleziona una pagina
InnovHeart appoints David Wilson as Chief Executive Officer

InnovHeart appoints David Wilson as Chief Executive Officer

da Martina Zanero | Mar 30, 2022 | Press release

Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth   InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System

InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System

da Martina Zanero | Gen 27, 2022 | Press release

InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China   Milan, January 27, 2022 – InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve...

Azin Parhizgar, Ph.D. Joins InnovHeart as Independent Member of the Board of Directors

da Martina Zanero | Gen 12, 2021 | Press release

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin Parhizgar, Ph.D. as an...

InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up

da Chiara | Set 24, 2020 | Press release

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...

Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million

da Chiara | Ago 7, 2020 | Press release

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing.  Founded in 2015 by Giovanni Righini, a 30-year veteran of...

InnovHeart Appoints J. Brent Ratz as Chief Executive Officer and Member of the Board

da Chiara | Ago 6, 2020 | Press release

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation, announced today the appointment of veteran medical device executive J. Brent Ratz to the role of Chief Executive Officer of the...
« Post precedenti

Headquarters

Via Giovannino de Grassi 11, 20123 Milano
Tel: +39 0236515110
Fax: +39 0236515115
info@innovheart.com

Cookies Policy
Privacy Policy

News & Press Release

  • Presentation of Saturn at TCT – September 2022
  • Presentation of Saturn at TVT 2022 – June 2022
  • InnovHeart appoints David Wilson as Chief Executive Officer

©COPYRIGHT - INNOVHEART SRL 2022 - Capitale sociale € 235.716,00 Cod.fisc.PIVA e Registro Imprese di Milano-Monza-Brianza-Lodi 09291430966 - REA di Milano 2081285